Abstract

Macroautophagy (autophagy) is believed to maintain energy homeostasis by degrading unnecessary cellular components and molecules. Its implication in regulating cancer metabolism recently started to be uncovered. However, the precise roles of autophagy in cancer metabolism are still unclear. Here, we show that autophagy plays a critical role in glutamine metabolism, which is required for tumor survival. Pancreatic ductal adenocarcinoma (PDAC) cells require both autophagy and typical glutamine transporters to maintain intracellular glutamine levels. Glutamine deprivation, but not that of glucose, led to the activation of macropinocytosis-associated autophagy through TFEB induction and translocation into the nucleus. In contrast, glutamine uptake increased as a compensatory response to decreased intracellular glutamine levels upon autophagy inhibition. Moreover, autophagy inhibition and glutamine deprivation did not induce cell death, while glutamine deprivation dramatically activated apoptotic cell death upon autophagy inhibition. Interestingly, the addition of α-ketoglutarate significantly rescued the apoptotic cell death caused by the combination of the inhibition of autophagy with glutamine deprivation. Our data suggest that macropinocytosis-associated autophagy is a critical process providing glutamine for anaplerosis of the TCA cycle in PDAC. Thus, targeting both autophagy and glutamine metabolism to completely block glutamine supply may provide new therapeutic approaches to treat refractory tumors.

Highlights

  • Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal malignancies in humans and continues to be a major medical challenge in the world

  • To explore the specific functional role of autophagy in cancer metabolism, we first investigated the effect of deprivation of either glucose or glutamine, two major nutrient sources for cancer cells, on autophagy in PDAC cell lines

  • The levels of p62/A170/SQSTM1 (p62), another marker of autophagy, which is known to be degraded by autophagy[21], decreased only in glutamine deprivation conditions, indicating that autophagy was only activated in response to glutamine deprivation

Read more

Summary

Introduction

Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal malignancies in humans and continues to be a major medical challenge in the world. It is the seventh leading cause of cancer death worldwide with a 5-year survival rate of 3–5%1. Targeting glutamine metabolism by inhibition of glutaminase significantly reduced PDAC growth, but had no effect on PDAC cell death. This lack of effect on PDAC cell death may be explained by the presence of other metabolic pathways to supply glutamine to the cells. Alternative therapeutic strategies may be developed to target PDAC-specific reliance on glutamine metabolism

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call